Prelude Therapeutics (PRLD) Capital Expenditures (QoQ) (2020 - 2025)
Prelude Therapeutics (PRLD) Capital Expenditures (QoQ) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
-57.45% |
| Mar 31, 2025 |
106.70% |
| Dec 31, 2024 |
-1,212.70% |
| Sep 30, 2024 |
-82.45% |
| Jun 30, 2024 |
24.22% |
| Mar 31, 2024 |
-74.40% |
| Dec 31, 2023 |
91.03% |
| Sep 30, 2023 |
-39.88% |
| Jun 30, 2023 |
21.36% |
| Mar 31, 2023 |
131.94% |
| Dec 31, 2022 |
-376.86% |
| Sep 30, 2022 |
-32.45% |
| Jun 30, 2022 |
283.05% |
| Mar 31, 2022 |
19.19% |
| Dec 31, 2021 |
-54.93% |
| Sep 30, 2021 |
-48.56% |
| Jun 30, 2021 |
1,389.53% |
| Mar 31, 2021 |
-87.26% |
| Dec 31, 2020 |
2,209.38% |
| Sep 30, 2020 |
-135.96% |
